Skip to Content

Nexviadyme 100 mg powder for concentrate for solution for infusion

Licence status
Authorised: 24/06/2022
Active substances
Avalglucosidase Alfa
Dosage Form
Powder for concentrate for solution for infusion
Licence number
EU/1/21/1579/001-004
Licence holder
Sanofi B.V.

Licence information

ATC code
A16AB22 avalglucosidase alfa
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
24/06/2022